Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion

  1. Postma, M.
  2. Fisman, D.
  3. Giglio, N.
  4. Márquez-Peláez, S.
  5. Nguyen, V.H.
  6. Pugliese, A.
  7. Ruiz-Aragón, J.
  8. Urueña, A.
  9. Mould-Quevedo, J.
Aldizkaria:
Vaccines

ISSN: 2076-393X

Argitalpen urtea: 2023

Alea: 11

Zenbakia: 6

Mota: Berrikuspena

DOI: 10.3390/VACCINES11061089 GOOGLE SCHOLAR lock_openSarbide irekia editor